This opportunity is no longer accepting applications.
grant PAR-22-126

Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)

This grant program supports high-risk exploratory research aimed at developing innovative technologies for biomedical research, emphasizing projects with potential for significant long-term impact. The initiative focuses on proof-of-concept studies to test feasibility and explore new technology development. Proposed projects must involve novel ideas with no established feasibility and should n…

This initiative will support exploratory research leading to the development of innovative technologies for biomedical research. The program will recognize and reward high risk approaches with potential for significant impact. Projects should entail a high degree of risk or novelty, which will b…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of General Medical Sciences
Program: SBIR

Dates

Application Window Closes: May 7, 2025
Opportunity Released: March 21, 2022
Open for Submission: March 21, 2022
Submission Deadline: May 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.